Summary
Renal biopsy specimens were evaluated from patients with different autoimmune diseases treated with cyclosporin (CyA). Ten biopsies were done before CyA, 10 biopsies after low-dose (<7.5 mg/kg/day, initial dose or mean daily dose within the first month, respectively), and 9 after high-dose (>7.5 mg/kg/day) treatment. Definite chronic CyA nephrotoxicity (cyclosporin-associated arteriolopathy and/or interstitial fibrosis striped form with tubular atrophy) was only present in the initial high-dose group. In this group a significant serum creatinine increase was noted and 8 of the 9 patients were hypertensive. No significant correlation was found between the severity of morphologic lesions and the mean daily dose during total treatment, cumulative dose, and duration of therapy. The morphologic changes in the low-dose group did not differ from the control biopsy specimens before CyA treatment. Based on these results, it can be concluded that major nephrotoxicity can be avoided by initial low CyA doses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CyA:
-
Cyclosporin A
- NSAID:
-
Nonsteroidal antiinflammatory drugs
- SLE:
-
Systemic lupus erythematosus
References
Bergstrand A, Bohman SO, Farnsworth A (1985) Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A. Clin Nephrol 24:107–119
Boitnott JK, Solez K (1984) The use of ranking in the statistical assessment of morphological data. In: Solez K, Whelton A (eds) Acute renal failure. Marcel Dekker, New York, Basle, pp 13–16
Farnsworth A, Hall BM, Ng ABP (1984) Renal biopsy morphology in renal transplantation. A comparative study of the light microscopic appearances of biopsies from patients treated with Cyclosporin A or azathioprine, prednisone and antilymphocyte globulin. Am J Surg Pathol 8:243–252
Feutren G, Querin S, Chatenoud L, Noël LH, Beaurain G, Lesavre P, Bach JF (1985) The effects of cyclosporin in twelve patients with severe systemic lupus. In: Schindler R (ed) Cyclosporin in autoimmune diseases. 1st Internationale Symposium, Basle. Springer, Berlin, Heidelberg, New York, pp 367–372
von Graffenried B, Harrison WB (1985) Renal function in patients with autoimmune disease treated with cyclosporin. Transplant Proc [Suppl 1] 17:215–131
Klintmalm G, Ringden O, Groth CG (1983) Clinical and laboratory signs in nephrotoxicity and rejection in cyclosporin-treated renal allograft recipients. Transplant Proc 15:2815–2820
Klintmalm G, Bohman SO, Sundelin B, Wilczek H (1984) Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low-doses in early post-transplantation period. Lancet II:950–953
Krupp P, Timonen O, Gülich A (1985) Side effects and safety of sandimmun in long-term treatment of transplant patients. In: Schindler R (ed) Cyclosporin in autoimmune disease. 1st International Symposium, Basle. Springer, Berlin, Heidelberg, New York, pp 43–49
Mihatsch MJ, Thiel G, Spichtin HP (1983) Morphological findings in kidney transplants after treatment with cyclosporin. Transplant Proc 15:2821–2835
Mihatsch MJ, Thiel G, Basler V (1985) Morphological paterns in cyclosporin-treated renal transplant recipients. Transpl Proc [Suppl 1] 17:101–116
Mihatsch MJ, Thiel G, Ryffel B (1985) Cyclosporin-associated nephropathy. In: Schindler R (ed) Cyclosporin in autoimmune diseases. 1st International Symposium, Basle. Springer, Berlin, Heidelberg, New York, pp 50–58
Myers BD, Ross J, Newton L (1984) Cyclosporin-associated chronic nephropathy. N Engl J Med 311:699–705
Palestine AG, Austin HA, Balow JE, Antonovych TT, Sabnis SG, Preuss HG, Nussenblatt RB, (1986) Renal histopathologic alterations in patients treated with cyclosporin for uveitis. N Engl J Med 314:1293–1298
Sibley RK, Ferguson RM, Sutherland DER (1983) Morphology of cyclosporin nephrotoxicity and of acute rejection in cyclosporin-prednisone immunosuppressed renal allograft recipients. Transplant Proc 15:2836–2841
Svenson K, Bohman SO Hallgren R (1985) Clinical effects and renal side effects in patients with autoimmune diseases treated with cyclosporin. In: Schindler R (ed) Cyclosporin in autoimmune diseases. 1st International Symposium, Basle. Springer, Berlin, Heidelberg, New York, pp 74–79
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mihatsch, M.J., Bach, J.F., Coovadia, H.M. et al. Cyclosporin-associated nephropathy in patients with autoimmune diseases. Klin Wochenschr 66, 43–47 (1988). https://doi.org/10.1007/BF01713009
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01713009